Randomized placebo control study of metformin in psoriasis patients with metabolic syndrome (systemic treatment cohort)

Background: Psoriasis has been found to be associated with obesity, metabolic syndrome (MS), diabetes, and cardiovascular risk factors. Metformin treatment showed improvement in cardiovascular risk factors and hyperinsulinemia. Objective: To evaluate the efficacy and safety of metformin in psoriasis...

Full description

Bibliographic Details
Main Authors: Surjit Singh, Anil Bhansali
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=4;spage=581;epage=587;aulast=Singh